Cardiac contractility modulation (CCM) in HFrEF NYHA Class III patients

27 May 2019 (09:00 - 09:10)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Daniel Burkhoff

Cardiovascular Research Foundation, New York (United States of America)

11 More presentations in this session

Presentation thumbnail

Reduction of Mitral Regurgitation in Patients with Heart Failure and Secondary Mitral Regurgitation: Relationship Between Baseline Biomarkers and Outcomes from the COAPT Trial

Professor W. Abraham (Columbus, US)

Presentation thumbnail

Discussion - COAPT.

Presentation thumbnail

A first in human multi-center, open label, prospective study to evaluate the safety, usability and performance of the V-LAP system

Professor W. Abraham (Columbus, US)

Presentation thumbnail

Discussion - A first in human multi-center, open label, prospective study to evaluate the safety, usability and performance of the V-LAP system.

Presentation thumbnail

Discussion - Cardiac contractility modulation (CCM) in HFrEF NYHA Class III patients.

Access the full session

Session thumbnail

Late breaking trial III - Innovative and device therapy

The Event

Heart Failure 2019

27 May 2019 09:00 CET

You may be interested in

Congress Presentation

Audience Q&A

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

Congress Session

Which device might help your HFpEF patient?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources